Extrapolation from this data suggests that only some 10%,b of postoperative liver damage is likely to be attributable to anaesthetic agents. Furthermore, we are currently engaged in a study of postoperative jaundice occurring in Great Britain and Eire. Up to the present time, in the majority of cases investigated, the jaundice is probably due to factors other than the anaesthetic agent used. However, it can be seen from Table IV on p. 21 that every case reported to the Committce on Safety of Drugs has been included in Figure 2 , p. 19. It is highly unlikely, therefore, that all of these cases are unexplained, and an "excess" of cases in which a cause and effect relationship is attributable to halothane may not exist. The high incidence of jaundice after operations repeated within a month remains of interest and concern. (Similar arguments may be applied to Figure 3.) We endorse the view that "the rare occurrence of jaundice after halothane anaesthesia is of much concern to anaesthetists." Regrettably, however, we conclude that the paper by Professor Mushin and his colleagues does not reduce the uncertainty as to whether or not halothane hepatitis exists. Indeed, the statement that "this complication could be avoided if the use of halothane were Lymphocyte Sensitization SiR,-We have read the recent study of lymphocyte sensitization in sarcoidosis by Dr. E. A. Caspary and Professor E. J. Field (17 April, p. 143) as shown by inhibition of macrophage migration. These authors also report two other patients who repeatedly failed to "convert" to tuberculin sensitivity after B.C.G., and who had lymphocytes sensitized to the same cell antigens as patients with sarcoidosis. This finding leads them to suggest that an extended study might show that "non-converted," although apparently healthy, subjects may exhibit the immunopathology of sarcoidosis.
We have investigated the phenomenon of apparently healthy subjects who remain 'non-converted" to tuberculin sensitivity following two vaccinations,'2 using both liquid and freeze-dried B.C.G. vaccine; each of our subjects showed satisfactory vaccination scars. In our first study' 7 out of 10 subjects who were vaccinated twice and who remained non-converted had positive Kveim tests. These seven subjects also showed marked depression of delayed- Firstly, certain important probabilities used in the matrix do not appear to fit the data from which they were derived. The Table giving survival figures should be corrected in the columns given below. It is appreciated that a monthly survival greater than 100 is unreal, but such parameters are meaningful when the average "matrix survival" for months 7 to 30 is calculated; this is 0-9897 (or 0-99) not 0.98 as given in the Table. (A simple graph of the survivals for these months illustrates that 0-99 gives a closer fit than does 0-98). It should be noted that this is the monthly survival for all states, and includes poorer survivals from states with poorer prognoses, such as the months following transplantation. The probabilities inserted in the matrix for the survival of patients following transplantation do not agree with those obtained from the Edinburgh data.' The Edinburgh data (for 35 patients) indicate survival at 1, 2, and 3 months of 86%, 70%, and 64% respectively. However, in the matrix higher probabilities lead from states 8, 9, and 10 to rejection (state 11) than to death (state 0). Analysis of the matrix in this region leads to survival at 1, 2, and 3 months following transplantation of 97%, 94%, and 90%
